Insider · CIK 0001887599
Daniel J. Curran
director
Files at CPRX (CATALYST PHARMACEUTICALS, INC.), ALXO (ALX ONCOLOGY HOLDINGS INC), XLO (Xilio Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | ALXO ALX ONCOLOGY HOLDINGS INC | AGrant or award Stock Option (right to buy)derivative | +16,833 | $0.00 | $0 | 16,833 | Jan 21, 2026 |
| Nov 20, 2025 | CPRX CATALYST PHARMACEUTICALS, INC. | AGrant or award Options to purchase common stockderivative | +18,115 | $0.00 | $0 | 58,115 | Nov 24, 2025 |
| Nov 20, 2025 | CPRX CATALYST PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +5,468 | $0.00 | $0 | 63,583 | Nov 24, 2025 |
| Aug 12, 2025 | ALXO ALX ONCOLOGY HOLDINGS INC | AGrant or award Stock option (right to buy)derivative | +40,400 | $0.00 | $0 | 40,400 | Aug 13, 2025 |
| Jun 11, 2025 | XLO Xilio Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Jun 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.